[An elderly case whose residual malignant lymphoma was completely remitted by oral etoposide treatment using unusual dosing schedule].
In a 72-year-old man with malignant lymphoma (Hodgkin's disease, nodular sclerosis type, Stage III S), complete remission was induced by intravenous drip of adriamycin and oral administration of etoposide. After that, a maintenance dose of etoposide (25 mg) was administered every 3 days without observable side effects. From these results, we considered that the dose level and interval of administration are both important for chemotherapy in elderly patients.